Ionis Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
Thanks so much for joining us.
Thanks, Jason. It's great to be here.
Questions & Answers
So the conversation, I think, is not surprisingly going to start with just the commercial opportunity for olezarsen in sHTG. And you've got an important FDA action date coming up here, June 30. So maybe just talk about how you're positioning for your first major launch as a company.
Commercially, you've launched this drug, TRYNGOLZA, for an ultra-orphan indication, but now you're migrating to the big league with a very big market, a more complicated probably end market, I would imagine. And so maybe just level set in terms of how Ionis is getting ready for kind of a transformational event for you as a company.
Yeah, sure. Let me begin with FCS because that's the current indication for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
